Accordingly, the overall expression level of Pax-5 in DLBCL and CLL cells was also significantly higher than normal B-cells, with changes of about 9.14- and 8.58-fold, respectively (p < 0.001). This evidence concerns the gene PAX5 and B-cell chronic lymphocytic leukemia.